18F-Fluorodeoxyglucose Positron Emission Tomography for the Detection of Myocardial Inflammation in Arrhythmogenic Left Ventricular Cardiomyopathy

Circ Cardiovasc Imaging. 2022 Jul;15(7):e014065. doi: 10.1161/CIRCIMAGING.122.014065. Epub 2022 Jun 30.

Authors

Roxane Tessier¹, Lara Marteau^{1

2}, Marc Vivien¹, Béatrice Guyomarch¹, Aurélie Thollet¹, Imen Fellah¹, Bastien Jamet³, Jean Charles Sébille³, Thomas Eugene³, Jean Michel Serfaty², Vincent Probst¹, Jean Noël Trochu¹, Claire Toquet^{1

4}, Karine Warin-Fresse², Nicolas Piriou^{1

3}

Affiliations

¹ CNRS, INSERM, l'institut du thorax (R.T., L.M., M.V., B.G., A.T., I.F., V.P., J.N., C.T., N.P.), CHU Nantes, Nantes Université, France.
² Department of Cardiovascular Radiology (L.M., J.M.S., K.W.-F.), CHU Nantes, Nantes Université, France.
³ Department of Nuclear Medicine (B.J., J.C.S., T.E., N.P.), CHU Nantes, Nantes Université, France.
⁴ Department of Pathology (C.T.), CHU Nantes, Nantes Université, France.

PMID: 35770631
DOI: 10.1161/CIRCIMAGING.122.014065

No abstract available

Keywords: MRI; PET-CT; arrhythmogenic cardiomyopathy; inflammation; myocarditis.

Publication types

Letter

MeSH terms

Cardiomyopathies* / diagnostic imaging
Cardiomyopathies* / etiology
Fluorodeoxyglucose F18
Humans
Inflammation / diagnostic imaging
Myocarditis* / diagnostic imaging
Positron Emission Tomography Computed Tomography / methods
Positron-Emission Tomography / methods
Radiopharmaceuticals

Substances

Radiopharmaceuticals
Fluorodeoxyglucose F18